Zoetis (ZTS) Return on Capital Employed Growth (3y) (2016 - 2026)
Zoetis (ZTS) Return on Capital Employed Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,902.00 |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | -96.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 331.00 |
| Dec 31, 2025 | 9.00 |
| Sep 30, 2025 | 19.00 |
| Jun 30, 2025 | 511.00 |
| Mar 31, 2025 | 510.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 660.00 |
| Jun 30, 2024 | 574.00 |
| Mar 31, 2024 | 863.00 |
| Dec 31, 2023 | 803.00 |
| Sep 30, 2023 | 1,281.00 |
| Jun 30, 2023 | 1,514.00 |
| Mar 31, 2023 | 1,233.00 |
| Dec 31, 2022 | 1,662.00 |
| Sep 30, 2022 | 1,736.00 |
| Jun 30, 2022 | 2,511.00 |
| Mar 31, 2022 | 3,344.00 |
| Dec 31, 2021 | 3,746.00 |
| Sep 30, 2021 | 3,650.00 |
| Jun 30, 2021 | 3,928.00 |